Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion

Fertility and Sterility

Volumn 82, Issue 5, 2004, Pages 1449-1451

  Endo, Toshiaki ^a   Kitajima, Yoshimitsu ^a   Hayashi, Takuhiro ^a   Fujii, Miho ^a   Hata, Hiroshi ^b   Azumaguchi, Atsushi ^c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Toho Hospital   (Japan)

^c Tonan Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEMOCONCENTRATION; HUMAN; INFUSION; INTERMETHOD COMPARISON; OVARY DISEASE; PRIORITY JOURNAL; THROMBOEMBOLISM;

ADULT; DEXTRANS; FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PLASMA SUBSTITUTES; SERUM ALBUMIN;

EID: 7944226361     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.04.045     Document Type: Article

References (25)

1. J.G. Shenker, D. Weinstein Ovarian hyperstimulation syndrome: a current survey Fertil Steril 30 1978 255 268
2. B. Rizk, M. Aboulghar Modern management of ovarian hyperstimulation syndrome Hum Reprod 6 1991 1082 1087
3. U. Elchalal, J.G. Schenker The pathophysiology of ovarian hyperstimulation syndrome Sem Reprod Endocrinol 14 1997 355 365
4. E. Mortier, M. Ongenae, L. Baerdemaeker, L. Herregods, N. Den Blauwen, J. Van Aken, G. Rolly In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% or coagulation profile measured by thromboelastography Anaesthesia 52 1997 1061 1064
5. G.A. Petroianu, J. Liu, W.H. Maleck, C. Mattinger, W.F. Bergler The effect of in vitro hemodilution with gelatin, dextran, hyroxyethyl starch, or Ringer's solution on thrombelastograph Anesth Analg 90 2000 795 800
6. P.A. Bergh, D. Navot Ovarian hyperstimulation syndrome: a review of pathophysiology J Assist Reprod Genet 9 1992 429 438
7. D. Navot, P.A. Bergh, N. Laufer Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment Fertil Steril 58 1992 249 261
8. F. Fabregues, J. Balasch, D. Manau, W. Jimenez, V. Arroyo, M. Creus Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome Hum Reprod 13 1998 2406 2410
9. D. Navot, P.A. Bergh, N. Laufer The ovarian hyperstimulation syndrome E.Y. Adashi J.A. Rock Z. Rosenwaks Reproductive endocrinology, surgery, and technology, vol. 2 1996 Lippincott-Raven Philadelphia
10. Y. Abramov, U. Elchalal, J.G. Schenker Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study Fertil Steril 71 1999 645 651
11. N.A. Rad, F.M. Helmerhorst OHSS and cerebrovascular thrombosis Hum Reprod 14 1999 1138
12. A. Schanzer, C.B. Rockman, G.R. Jacobowitz, T.S. Riles Internal jugular vein thrombosis in association with the ovarian hyperstimulation syndrome J Vasc Surg 31 2000 815 818
13. I.M. Turkistani, S.A. Ghourab, O.H. Al-Sheikh, A.M. Abuel-Asral Central retinal artery occlusion associated with severe ovarian hyperstimulation syndrome Eur J Ophthalmol 11 2001 313 315
14. T. Levy, R. Orvieto, R. Homburg, D. Peleg, A. Dekel, Z. Ben-Rafael Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient Hum Reprod 11 1996 1177 1179
15. M.A.A. Aboulghar, R.T. Mansour, G.I. Serour, Y.M. Amin Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis Hum Reprod 13 1998 2088 2091
16. R.H. Asch, G. Ivery, M. Goldsman, J.L. Frederick, S.C. Stone, J.P. Balmaceda The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome Hum Reprod 8 1993 1015 1020
17. Z. Shoham, A. Weissman, A. Barash, R. Borenstein, M. Schachter, V. Insler Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study Fertil Steril 62 1994 137 142
18. H.G. Al-Inany Human albumin is effective in prevention of severe OHSS Acta Obstet Gynecol Scand 80 2001 878 882
19. Y. Mukherjee, A.B. Copperman, B. Sandler, M. Bustillo, L. Grunfeld Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer Fertil Steril 64 1995 641 643
20. E. Ng, A. Leader, P. Claman, M. Domingo, J.E. Spence Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme Hum Reprod 10 1995 807 810
21. A. Ben-Chetrit, T. Eldar-Geva, M. Gal, M. Huerta, T. Mimon, N. Algur The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial Hum Reprod 16 2001 1880 1884
22. M.R. Fluker, J.E. Copeland, A.A. Yuzpe An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome Fertil Steril 73 2000 821 824
23. S.R. Lincoln, M.S. Opsahl, K.L. Blauer, S.H. Black, J.D. Schulman Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization J Assist Reprod Genet 19 2002 159 163
24. Y. Abramov, M. Fatum, D. Abrahamov, J.G. Schenker Hydroxyethyl starch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report Fertil Steril 75 2001 1228 1230
25. D. Rabinerson, Z. Ben Rafael, J. Keslin, V. Zolotarsky, A. Dekel 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome A case report J Reprod Med 46 2001 68 70